MultiMedica for Companies

Annual Screening Package (Mustang Corporate Edition)

What is it about?
It is a targeted 12-month diagnostic and monitoring pathway for the benefit of a company’s employees, consisting of occupational medicine clinical services useful in preventing and contrasting/containing the spread of SARS-CoV-2 in the workplace.

The product is provided by AIECS S.r.l. (a company of the Gruppo MultiMedica specialized in Occupational Medicine) on a solvency basis, with the cost borne by the company, in order to protect both the health of its employees and the continuity of the company, in the interest of all stakeholders.

In the current context of MultiMedica we have developed the conviction that, only with a continuous approach, we can adequately address the issue of prevention and containment of the virus in the specific context of a community, at least in the next 10/12 months.

In this perspective, our physicians and researchers – strengthened by the clinical experience gained “on the battlefield”, as well as by the scientific evidence of the Mustang Occupation trial – have developed a set of personalized and repeated diagnostic/clinical paths: the Mustang Corporate Edition.
This product intends to differentiate itself from the “spot” screening interventions available on the market (also offered by MultiMedica) in order to support, in a structured and continuous way, companies and workers in the long path that still awaits us before exiting the tunnel of the pandemic, all in a context of a balanced cost/benefit ratio.

The price of the Mustang Corporate Edition varies depending on the number of company employees involved in the screening. For information on the prices of the services and of the diagnostic paths useful for the prevention, surveillance, contrast and containment of the diffusion of the SARS-CoV-2 virus in the working environments, the Companies can contact:


Centro Medico Polispecialistico AIECS S.r.l.
Monday to Friday from 9 am to 17 pm
Mail to: gisella.arosio@multimedica.it